Anzeige
Mehr »
Mittwoch, 10.12.2025 - Börsentäglich über 12.000 News
Diese Biotech-News am 11. Dezember könnte 2026 komplett verändern
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Investing.com

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
DiBlackstone-affiliated stockholders to sell 7 million Legence shares
DiStifel upgrades Arcellx stock, cites buying opportunity after share weakness
DiAble View Global receives Nasdaq minimum bid price deficiency notice
DiTJX Companies declares quarterly dividend of $.425 per share
DiLilly to build $6 billion manufacturing facility in Alabama
DiJPMorgan stock price target lowered to $331 at Morgan Stanley on higher expenses
DiOmnicell stock price target raised by BofA to $46 on new cabinet launch
DiFerrari stock price target lowered to €310 at Jefferies on model ramp-up costs
DiHII hosts keel laying ceremony for Virginia-class submarine Barb
DiM-tron Industries extends warrant expiration date to December 23
DiJefferies raises Kymera Therapeutics stock price target to $122 on KT-621 data
DiBorr Drilling prices $165 million in additional senior secured notes
DiG-III Apparel stock price target raised to $34 by BTIG on strong margins
DiSezzle to join S&P SmallCap 600 index effective December 12
DiMorgan Stanley initiates Ferrari stock with Equalweight rating
DiMarathon Petroleum stock rating reiterated at Outperform by BMO Capital
DiEx-Slack CEO Denise Dresser joins OpenAI as Chief Revenue Officer
DiBluSky AI appoints Riley Cooney as corporate development officer
DiTeleflex stock holds steady as Needham maintains rating amid asset sales
DiChallenger Energy, Sintana Energy merger advances with ANCAP approval
DiHigh court approves Power Metal Resources' share capital reduction
DiKorn Ferry Q2 FY'26 slides: revenue up 7%, EMEA region leads with 20% growth
DiWalmart stock transitions to Nasdaq as Jefferies reiterates Buy rating
DiLegend Biotech stock remains Outperform at RBC despite competitive threats
DiPACCAR declares $1.40 per share extra dividend payable in January